Formulation and evaluation of thymoquinone niosomes: application of developed and validated RP-HPLC method in delivery system

References

• Akhtar M, Imam SS, AhmadAM, et al. Neuroprotective study of Nigella sativa loaded oral provesicular lipid formulation: in-vitro and ex-vivo study. Drug Deliv. 2014;21(6):487–494.
   PubMed Web of Science ®Google Scholar
• Salmani JM, Asghar S, Lv H, et al. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules. 2014;19(5):5925–5939.
   PubMed Web of Science ®Google Scholar
• Alkharfy KM, Ahmad A, Khan RM, et al. Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. Eur J Drug Metab Pharmacokinet. 2015;40(3):319–323.
   PubMed Web of Science ®Google Scholar
• Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol.. 2005;5(13–14):1749–1770.
   PubMed Web of Science ®Google Scholar
• Iqbal MS, Ansari MI, Ahmad I, et al. Morpho-physiological characterization of seeds and seedlings of Nigella sativa Linn.: study on Indian germplasm. Int Res J Biol Sci. 2015;4(4):38–42.
   Google Scholar
• Fakhria A, Gilani SJ, Imam SS, et al. Formulation of thymoquinone loaded chitosan nano vesicles: in-vitro evaluation and in-vivo anti-hyperlipidemic assessment. J Drug Del Sci Tech. 2019;50:339–346.
   Web of Science ®Google Scholar
• Ali A, Ali S, Aqil M, et al. Thymoquinone loaded dermal lipid nano particles: Box Behnken design optimization to preclinical psoriasis assessment. J Drug Del Sci Tech. 2019;52:713–721.
   Web of Science ®Google Scholar
• Nihei T, Suzuki H, Aoki A, et al. Development of a novel nanoparticle formulation of thymoquinone with a cold wet-milling system and its pharmacokinetic analysis. Int J Pharm. 2016;511(1):455–461.
   PubMedGoogle Scholar
• Alam M, Najmi AK, Ahmad I, et al. Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in-vitro assessment and bioactivity detail in rats. Artif Cells Nanomed Biotechnol. 2018;46(Suppl 2):46–57.
   PubMedGoogle Scholar
• Rani R, Dahiya S, Dhingra D, et al. Improvement of antihyperglycemic activity of nano-thymoquinone in rat model of type-2 diabetes. Chem Biol Interact. 2018;295:119–132.
   PubMed Web of Science ®Google Scholar
• Taleuzzaman M, Gilani SJ. Analytical profile of anti-diabetic constituents – thymoquinone from seed of Nigella Sativa. Int J Chem Tech Res. 2017;10(9):139–147.
   Google Scholar
• Basha LI, Abou MSR, Aboul-Enein HY. TLC assay of thymoquinone in black seed oil (Nigella sativa Linn) and identification of dithymoquinone and thymol. J Liq Chromat. 1995;18(1):105–115.
   Web of Science ®Google Scholar
• Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal. 1999;19(5):757–762.
   PubMed Web of Science ®Google Scholar
• Iqbal MS, Ahmad A, Pandey B. Solvent based optimization for extraction and stability of thymoquinone from Nigella sativa Linn. and its quantification using RP-HPLC. Physiol Mol Biol Plants. 2018;24(6):1209–1219.
   PubMed Web of Science ®Google Scholar
• Aboul-Enein HY, Abou-Basha LI. Simple HPLC method for the determination of thymoquinone in black seed oil (Nigella sativa Linn). J Liquid Chromat. 1995;18(5):895–902.
   Web of Science ®Google Scholar
• Velho-Pereira RM, Barhate CR, Kulkarni SR, et al. Validated high-performance thin-layer chromatographic method for the quantification of thymoquinone in Nigella sativa extracts and formulations. Phytochem Anal. 2011;22(4):367–373.
   PubMed Web of Science ®Google Scholar
• Taleuzzaman M, Imam SS, Gilani SJ. Quantitative determination of thymoquinone in Nigella sativa and its nano formulation using validated stability indicating HPTLC densiometric method. Int Curr Pharm J. 2018;6(10):53–60.
   Google Scholar
• Lobenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm. 2000;50:3–12.
   PubMed Web of Science ®Google Scholar
• Shakeel K, Raisuddin S, Ali S, et al. Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery. J Lip Res. 2019;29(1):35–43.
   Google Scholar
• Sayeed S, Imam SS, Najmi AK, et al. Nonionic surfactant based thymoquinone loaded nanoproniosomal formulation: in vitro physicochemical evaluation and in vivo hepatoprotective efficacy. Drug Dev Ind Pharm. 2017;43(9):1413–1420.
   PubMed Web of Science ®Google Scholar
• Imam SS, Aqil M, Akhtar M, et al. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv. 2015;22(8):1059–1070.
   PubMed Web of Science ®Google Scholar
• Jamal M, Imam SS, Aqil M, et al. Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems. Int Immunopharmacol. 2015;29(2):361–369.,
   PubMed Web of Science ®Google Scholar
• Abidin L, Mujeeb M, Imam SS, et al. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment. Drug Deliv. 2016;23(3):1069–1074.
   Web of Science ®Google Scholar
• Imam SS, Aqil M, Akhtar M, et al. Optimization of mobile phase by 32-mixture design for the validation and quantification of risperidone in bulk and pharmaceutical formulations using RP-HPLC. Anal Methods. 2014;6(1):282–288.
   Web of Science ®Google Scholar
• Moghddam SR, Ahad A, Aqil M, et al. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mater Sci Eng C Mater Biol Appl. 2016;69:789–797.
   PubMed Web of Science ®Google Scholar
• Kapoor H, Aqil M, Imam SS, et al. Formulation of amlodipine nano lipid carrier: formulation design, physicochemical and transdermal absorption investigation. J Drug Del Sci Tech. 2019;49:209–218.
   Web of Science ®Google Scholar
• Detroja C, Chavhan S, Sawant K. Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study. Sci Pharm. 2011;79(3):635–651.
   PubMedGoogle Scholar
• Costa P, Lobo J. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–133.
   PubMed Web of Science ®Google Scholar
• Jahangir MA, Khan R, Imam SS. Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance. Art Cells Nanomed Biotech. 2018;46(Suppl 1):66–78.
   PubMedGoogle Scholar
• Alsarra IA, Bosela AA, Ahmed SM, et al. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm. 2005;59(3):485–490.
   PubMed Web of Science ®Google Scholar
• Ertekin ZC, Bayindir ZS, Yuksel N. Stability studies on piroxicam encapsulated niosomes. Curr Drug Deliv. 2015;12(2):192–199.
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm. 2009;377(1–2):1–8.
   PubMed Web of Science ®Google Scholar
• Gulati M, Grover M, Singh S, et al. Lipophilic drug derivatives in liposomes. Int J Pharm. 1998;165(2):129–168.,
   Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. Nonionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172(1–2):33–70.
   Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328(2):130–141.
   PubMed Web of Science ®Google Scholar
• Csoka G, Marton S, Zelko R, et al. Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm. 2007;65(2):233–237.
   PubMed Web of Science ®Google Scholar
• Al-Zahraa MK, Bazigha K, Rasool A. Optimized mucoadhesive coated niosomes as a sustained oral delivery system of famotidine. AAPS Pharm Sci Tech. 2017;18(8):3064–3075.
   PubMed Web of Science ®Google Scholar
• Mokale VJ, Patil HI, Patil AP, et al. Formulation and optimisation of famotidine proniosomes: an in vitro and ex vivo study. J Exp Nanosci. 2016;11(2):97–110.
   Web of Science ®Google Scholar
• Fang JY, Hong CT, Chiu WT, et al. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm. 2001;219(1–2):61–72.
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77(1):43–55.
   PubMed Web of Science ®Google Scholar